[go: up one dir, main page]

DK227183D0 - Fremgangsmade til fremstilling af imidazo (1,2-c)-pyrazolo(3,4-e) pyrimidiner med den almene formel i - Google Patents

Fremgangsmade til fremstilling af imidazo (1,2-c)-pyrazolo(3,4-e) pyrimidiner med den almene formel i

Info

Publication number
DK227183D0
DK227183D0 DK2271/83A DK227183A DK227183D0 DK 227183 D0 DK227183 D0 DK 227183D0 DK 2271/83 A DK2271/83 A DK 2271/83A DK 227183 A DK227183 A DK 227183A DK 227183 D0 DK227183 D0 DK 227183D0
Authority
DK
Denmark
Prior art keywords
pyrazolo
pyrimidines
general formula
preparing imidazo
imidazo
Prior art date
Application number
DK2271/83A
Other languages
English (en)
Other versions
DK161968C (da
DK227183A (da
DK161968B (da
Inventor
Horace A Dewald
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK227183D0 publication Critical patent/DK227183D0/da
Publication of DK227183A publication Critical patent/DK227183A/da
Publication of DK161968B publication Critical patent/DK161968B/da
Application granted granted Critical
Publication of DK161968C publication Critical patent/DK161968C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK227183A 1982-05-24 1983-05-20 Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf DK161968C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/381,484 US4469868A (en) 1982-05-24 1982-05-24 Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines
US38148482 1982-05-24

Publications (4)

Publication Number Publication Date
DK227183D0 true DK227183D0 (da) 1983-05-20
DK227183A DK227183A (da) 1983-11-25
DK161968B DK161968B (da) 1991-09-02
DK161968C DK161968C (da) 1992-02-03

Family

ID=23505215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK227183A DK161968C (da) 1982-05-24 1983-05-20 Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf

Country Status (22)

Country Link
US (1) US4469868A (da)
EP (1) EP0095289B1 (da)
JP (1) JPS58210087A (da)
KR (1) KR870000931B1 (da)
AR (1) AR240941A1 (da)
AT (1) ATE24510T1 (da)
AU (1) AU553708B2 (da)
CA (1) CA1210393A (da)
DE (1) DE3368635D1 (da)
DK (1) DK161968C (da)
ES (4) ES8407051A1 (da)
FI (1) FI74012C (da)
GR (1) GR79262B (da)
HK (1) HK102989A (da)
HU (1) HU187913B (da)
IE (1) IE55111B1 (da)
IL (1) IL68360A0 (da)
NO (1) NO160444C (da)
NZ (1) NZ204321A (da)
PH (1) PH18454A (da)
PT (1) PT76745B (da)
ZA (1) ZA832637B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
AU2005323311A1 (en) * 2004-11-23 2006-07-13 Venkateswara Rao Batchu Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
WO2006133261A2 (en) 2005-06-06 2006-12-14 Intra-Cellular Therapies, Inc. Organic compounds
EP2089034A4 (en) 2006-12-05 2010-07-28 Intra Cellular Therapies Inc NEW USES
EA201170769A1 (ru) 2008-12-06 2012-02-28 Интра-Селлулар Терапиз, Инк. Органические соединения
WO2010132127A1 (en) 2009-05-13 2010-11-18 Intra-Cellular Therapies, Inc. Organic compounds
EP2576551A4 (en) 2010-05-31 2014-04-16 Intra Cellular Therapies Inc ORGANIC CONNECTIONS
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
CN103492389B (zh) * 2011-04-21 2016-09-14 原真股份有限公司 用作激酶抑制剂的吡唑并[4,3-d]嘧啶
US9637491B2 (en) 2012-10-19 2017-05-02 Origenis Gmbh Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
EP2956141A4 (en) 2013-02-17 2016-10-26 Intra Cellular Therapies Inc NEW USES
EP3479825B1 (en) 2013-03-15 2021-02-17 Intra-Cellular Therapies, Inc. Pde1 inhibitors for use in the treatment and/or prevention of cns or pns diseases or disorders
AU2014234990B2 (en) 2013-03-15 2017-11-16 Intra-Cellular Therapies, Inc. Organic compounds
WO2015196186A1 (en) 2014-06-20 2015-12-23 Intra-Cellular Therapies, Inc. Organic compounds
US10131671B2 (en) 2014-08-07 2018-11-20 Intra-Cellular Therapies, Inc. Organic compounds
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
RU2711442C2 (ru) 2014-09-17 2020-01-17 Интра-Селлулар Терапиз, Инк. Соединения и способы
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US11291666B2 (en) 2016-09-12 2022-04-05 Intra-Cellular Therapies, Inc. Uses
EP3746081A4 (en) 2018-01-31 2021-10-27 Intra-Cellular Therapies, Inc. Novel uses
US12410175B2 (en) 2019-09-03 2025-09-09 Intra-Cellular Therapies, Inc. Compounds
US12364695B2 (en) 2020-06-02 2025-07-22 Intra-Cellular Therapies, Inc. Methods of treating inflammatory disease

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3309369A (en) * 1966-04-11 1967-03-14 Wander Ag Dr A Imidazo- and pyrimido-quinazolines
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
DE2058501A1 (de) * 1970-11-27 1972-05-31 Bayer Ag Verfahren zur Herstellung von neuen N-verbrueckten bicyclischen Heteroaromaten
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
US3984556A (en) * 1973-01-19 1976-10-05 Sandoz, Inc. Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure
JPS516993A (en) * 1974-07-05 1976-01-20 Dainippon Pharmaceutical Co Adeninjudotaino seiho
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
US4250181A (en) * 1977-10-31 1981-02-10 The Upjohn Company Methods of treating psychosis
US4247553A (en) * 1977-10-31 1981-01-27 The Upjohn Company Methods of treating psychosis
US4206123A (en) * 1977-10-31 1980-06-03 Mccall John M Isothiochroman
US4192803A (en) * 1978-09-15 1980-03-11 American Cyanamid Company 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives
BG33279A3 (en) * 1978-11-01 1983-01-14 The Wellcome Foundation Limited Method for making of carbazole compounds
CH643263A5 (de) * 1979-05-11 1984-05-30 Sandoz Ag Benzodiazepine, ihre herstellung und verwendung.
HU178523B (en) * 1979-05-18 1982-05-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing new pyrazolo-quinazoline derivatives
US4230707A (en) * 1979-08-27 1980-10-28 Warner-Lambert Company Oxo-pyrido[1,2-a]thienopyrimidine compounds and methods for their production
US4358456A (en) * 1980-05-03 1982-11-09 John Wyeth & Brother Limited Antipsychotic piperidinomethyl-indole derivatives
US4396770A (en) * 1982-04-09 1983-08-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4374245A (en) * 1982-04-09 1983-02-15 Hoechst-Roussel Pharmaceuticals Inc. 8-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
US4390544A (en) * 1982-04-09 1983-06-28 Hoechst-Roussel Pharmaceuticals Inc. {1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(2-oxo-1-benzimidazolinyl}p
US4415581A (en) * 1982-04-09 1983-11-15 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines to treat psychoses
US4409230A (en) * 1982-04-09 1983-10-11 Hoechst-Roussel Pharmaceuticals Inc. Pharmaceutical compositions and methods employing 8-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro-[4.]decan-4-one and derivatives thereof
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol

Also Published As

Publication number Publication date
NO160444C (no) 1989-04-19
ES529372A0 (es) 1985-06-16
HK102989A (en) 1990-01-05
DK161968C (da) 1992-02-03
IL68360A (en) 1986-10-31
ES522617A0 (es) 1984-09-01
ES8407051A1 (es) 1984-09-01
FI74012B (fi) 1987-08-31
ES8506315A1 (es) 1985-07-01
CA1210393A (en) 1986-08-26
ES8506019A1 (es) 1985-06-16
FI831742A0 (fi) 1983-05-18
NO160444B (no) 1989-01-09
PH18454A (en) 1985-07-18
IE55111B1 (en) 1990-06-06
KR840004756A (ko) 1984-10-24
AR240941A2 (es) 1991-03-27
ES529373A0 (es) 1985-06-16
JPH0320395B2 (da) 1991-03-19
AU1342783A (en) 1983-12-01
NZ204321A (en) 1986-06-11
KR870000931B1 (ko) 1987-05-11
ATE24510T1 (de) 1987-01-15
AR240941A1 (es) 1991-03-27
PT76745A (en) 1983-06-01
FI831742L (fi) 1983-11-25
GR79262B (da) 1984-10-22
FI74012C (fi) 1987-12-10
PT76745B (en) 1986-04-21
ZA832637B (en) 1984-01-25
EP0095289A3 (en) 1984-09-05
IE830822L (en) 1983-11-24
EP0095289B1 (en) 1986-12-30
AU553708B2 (en) 1986-07-24
DK227183A (da) 1983-11-25
DE3368635D1 (en) 1987-02-05
DK161968B (da) 1991-09-02
ES8506004A1 (es) 1985-06-16
HU187913B (en) 1986-03-28
NO831792L (no) 1983-11-25
IL68360A0 (en) 1986-10-31
US4469868A (en) 1984-09-04
ES529371A0 (es) 1985-07-01
JPS58210087A (ja) 1983-12-07
EP0095289A2 (en) 1983-11-30

Similar Documents

Publication Publication Date Title
DK227183D0 (da) Fremgangsmade til fremstilling af imidazo (1,2-c)-pyrazolo(3,4-e) pyrimidiner med den almene formel i
DK120783D0 (da) Fremgangsmade til fremstilling af substituerede 1h-pyrazolo(1,5-a)pyrimidiner
ES531285A0 (es) Procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-(3,4-c)-piridina
NO874302L (no) Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo(1,5-a)pyrimidiner.
FI834665A0 (fi) Imidazo(1,5-a)pyridin-derivat
AR229519A1 (es) Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio
DK390583D0 (da) Fremgangsmade til fremstilling af imidazo(1,2-a)pyrimidiner
PT71197A (en) Process for the preparation of substituted pyrido/1,2-a/pyrimidines
PT75240A (en) Process for the preparation of substituted thiazolo <3,2-a>pyrimidines
FI834664A0 (fi) Substituerade imidazo(1,5-a)pyridiner
DK44383D0 (da) Fremgangsmade til fremstilling af substituerede 1,3,4-thiadiazolo(3,2-a)pyrimidiner
DK584484D0 (da) Kemisk fremgangsmaade til fremstilling af antibiotikum l 17054
DK96379A (da) Fremgangsmaade til fremstilling af disubstituerede 2,3-dihydroimidazo (1,2-c)-pyrimidiner
DK288079A (da) Fremgangsmaade til fremstilling af imidazolylethoxyderivater af pyrazolo (3,4-b) pyridin-5-methanoler
DK367388D0 (da) Til fremstilling af hoejredrejende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)thiazol-7-carboxylsyre
DK133883D0 (da) Fremgangsmade til fremstilling af substituerede ethenylderivater af 1h-pyrazolo(1,5-a)pyrimidin
DK108283A (da) Fremgangsmaade til fremstilling af pentacycliske forbindelser
DK154971C (da) Fremgangsmaade til fremstilling af phenylpyridazinforbindelser
PT75244A (de) Verfahren zur herstellung von 5,11-dihydro-6h-pyrido <2,3-b>-<1,4> benzodiazepin-6-onen
DK192683D0 (da) Fremgangsmade til fremstilling af kondenserede cycloaliphatiske derivater af substituerede (1,2-a)pyrimidiner
DK55783A (da) Fremgangsmaade til fremstilling af 1-substitueret-6-n-propyl-8-methylimidazo(1,5-d)-as-triazin-4(3h)-oner
AR227783A1 (es) Procedimiento para preparar derivados de 4,5,7,8-tetrahidro-4,4,8,8-tetrametil-1-h-tiepin(4,5-d)imidazol
ATA416882A (de) Verfahren zur herstellung von neuen spiro-derivaten des pyrazolo (1,5-d) (1,2,4) triazin-ring-systems
IT8048792A0 (it) Composti di imidazo (1,5-d)as-triazin-4(3h)-oni e -tioni sostituiti e procedimento per laloro preparazione
GR860095B (en) Method for the preparation of novel heterocyclic compounds

Legal Events

Date Code Title Description
PBP Patent lapsed